CYMBF yields 3.06% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, CYMBF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CYMBF + JNJ for your $10,000?
Cymbria Corporation is a closed ended equity fund launched and managed by EdgePoint Investment Group Inc. The fund invests in the public equity markets across the globe. It also invests some portion of its portfolio in derivative instruments, privately held businesses or leverage its investments. The fund holds a substantial amount of investment in EdgePoint Wealth Management. Inc. It invests in the stocks of companies operating across diversified sectors. The fund invests in the value stocks of companies across all market capitalizations. It focuses on factors like proprietary insights, long term views, focus on growth, extensive research, incisive analysis, and assessment of value sums up to create its portfolio. The fund benchmarks the performance of its portfolio against the MSCI World Index (C$). Cymbria Corporation was formed on September 4, 2008 and is domiciled in Canada.
Full CYMBF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.